To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years
Conditions: Diphtheria; Tetanus; Pertussis; Poliomyelitis Intervention: Biological: DTaP-IPV combination vaccine Sponsor: Boryung Biopharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials